Literature DB >> 3753644

Unusual locations of localized myxedema in Graves' disease. Report of three cases.

N Noppakun, K Bancheun, S Chandraprasert.   

Abstract

Three patients with Graves' disease had very unusual locations of localized myxedema. One patient had localized myxedema on the pretibial and shoulder areas after sodium iodide I 131 therapy. The second patient had localized myxedema on his neck, shoulders, and upper part of the back as well as on the pretibial area. The third patient had localized myxedema on the pinnae, also following sodium iodide I 131 therapy. After surgical removal followed by intralesional triamcinolone acetonide injections, the first patient's lesions recurred. The lesions in the second case did not respond to topical steroid cream. The third patient had a partial response to intralesional steroid injections.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3753644

Source DB:  PubMed          Journal:  Arch Dermatol        ISSN: 0003-987X


  6 in total

1.  Localized myxedema on the nasal dorsum in a patient with Graves' disease: report of a case.

Authors:  F Akasu; K Takazawa; R Akasu; T Onaya
Journal:  J Endocrinol Invest       Date:  1989-11       Impact factor: 4.256

2.  Localized myxedema of the foot associated with trauma and surgery.

Authors:  Bernard P Luczak; Jennifer Ha; Lip G Teh
Journal:  Ochsner J       Date:  2011

3.  Pretibial Myxedema in a Euthyroid Patient.

Authors:  Stephen Ansah-Addo; Andrew F Alexis
Journal:  J Clin Aesthet Dermatol       Date:  2021-01-01

4.  Orbital decompression in Graves' ophthalmopathy associated with pretibial myxedema.

Authors:  V Fatourechi; J A Garrity; G B Bartley; E J Bergstralh; C A Gorman
Journal:  J Endocrinol Invest       Date:  1993-06       Impact factor: 4.256

Review 5.  Extrathyroidal manifestations of Graves' disease: a 2014 update.

Authors:  Luigi Bartalena; Vahab Fatourechi
Journal:  J Endocrinol Invest       Date:  2014-06-10       Impact factor: 4.256

6.  Treatment of pretibial myxedema with intralesional immunomodulating therapy.

Authors:  Ziwei Ren; Min He; Fang Deng; Yan Chen; Liyin Chai; Bing Chen; Wuquan Deng
Journal:  Ther Clin Risk Manag       Date:  2017-09-08       Impact factor: 2.423

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.